Tower Research Capital (TRC)’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$94.4K Buy
6,891
+5,571
+422% +$76.3K ﹤0.01% 2428
2025
Q1
$14.4K Sell
1,320
-265
-17% -$2.88K ﹤0.01% 3300
2024
Q4
$16.9K Sell
1,585
-193
-11% -$2.06K ﹤0.01% 3337
2024
Q3
$22.6K Sell
1,778
-1,590
-47% -$20.2K ﹤0.01% 3173
2024
Q2
$56.5K Buy
3,368
+3,181
+1,701% +$53.4K ﹤0.01% 3006
2024
Q1
$2.81K Sell
187
-1,504
-89% -$22.6K ﹤0.01% 4978
2023
Q4
$25.4K Sell
1,691
-8,699
-84% -$130K ﹤0.01% 3512
2023
Q3
$146K Buy
10,390
+9,686
+1,376% +$136K ﹤0.01% 1685
2023
Q2
$7.29K Sell
704
-1,074
-60% -$11.1K ﹤0.01% 4568
2023
Q1
$16K Buy
1,778
+37
+2% +$333 ﹤0.01% 3741
2022
Q4
$15K Sell
1,741
-637
-27% -$5.49K ﹤0.01% 3455
2022
Q3
$20K Sell
2,378
-135
-5% -$1.14K ﹤0.01% 3946
2022
Q2
$21K Buy
2,513
+1,424
+131% +$11.9K ﹤0.01% 3764
2022
Q1
$9K Sell
1,089
-1,116
-51% -$9.22K ﹤0.01% 4500
2021
Q4
$21K Buy
2,205
+1,605
+268% +$15.3K ﹤0.01% 3625
2021
Q3
$10K Sell
600
-2,694
-82% -$44.9K ﹤0.01% 4340
2021
Q2
$50K Sell
3,294
-1,256
-28% -$19.1K ﹤0.01% 3028
2021
Q1
$88K Sell
4,550
-1,138
-20% -$22K ﹤0.01% 2685
2020
Q4
$103K Sell
5,688
-15,408
-73% -$279K ﹤0.01% 2322
2020
Q3
$407K Buy
21,096
+18,263
+645% +$352K ﹤0.01% 1911
2020
Q2
$74K Buy
+2,833
New +$74K ﹤0.01% 2731
2020
Q1
Sell
-596
Closed -$20K 3929
2019
Q4
$20K Sell
596
-1,404
-70% -$47.1K ﹤0.01% 1930
2019
Q3
$47K Buy
2,000
+1,875
+1,500% +$44.1K ﹤0.01% 1841
2019
Q2
$4K Sell
125
-2,854
-96% -$91.3K ﹤0.01% 3061
2019
Q1
$110K Buy
2,979
+2,636
+769% +$97.3K 0.01% 1395
2018
Q4
$15K Sell
343
-344
-50% -$15K ﹤0.01% 2176
2018
Q3
$32K Buy
687
+549
+398% +$25.6K ﹤0.01% 2039
2018
Q2
$7K Sell
138
-59
-30% -$2.99K ﹤0.01% 2969
2018
Q1
$10K Buy
+197
New +$10K ﹤0.01% 2471
2017
Q4
Sell
-318
Closed -$10K 4124
2017
Q3
$10K Buy
318
+39
+14% +$1.23K ﹤0.01% 3080
2017
Q2
$5K Buy
+279
New +$5K ﹤0.01% 2020